© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Statement of Principles concerning optochiasmatic arachnoiditis (Balance of Probabilities) (No. 96 of 2025)
Start here
Turn the raw legal text into a practical explanation grounded in Statement of Principles concerning optochiasmatic arachnoiditis (Balance of Probabilities) (No. 96 of 2025).
?xml version="1.0" encoding="utf-8" standalone="no"?>
RMA Australian Government Coat of Arms
Statement of Principles
concerning
OPTOCHIASMATIC ARACHNOIDITIS (Balance of Probabilities)
(No. 96 of 2025)
The Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(3) of the Veterans' Entitlements Act 1986.
Dated 24 October 2025
Professor Terence Campbell AM
Chairperson
by and on behalf of
The Repatriation Medical Authority
Contents
1 Name
2 Commencement
3 Authority
4 Repeal
5 Application
6 Definitions
7 Kind of injury, disease or death to which this Statement of Principles relates
8 Basis for determining the factors
9 Factors that must exist
10 Relationship to service
11 Factors referring to an injury or disease covered by another Statement of Principles
Schedule 1 - Dictionary
1 Definitions
This is the Statement of Principles concerning optochiasmatic arachnoiditis (Balance of Probabilities) (No. 96 of 2025).
This instrument commences on 24 November 2025.
This instrument is made under subsection 196B(3) of the Veterans' Entitlements Act 1986.
The Statement of Principles concerning optochiasmatic arachnoiditis (Balance of Probabilities) (No. 58 of 2016) (Federal Register of Legislation No. F2016L00568) made under subsections 196B(3) and (8) of the VEA is repealed.
This instrument applies to a claim to which section 120B of the VEA or section 339 of the Military Rehabilitation and Compensation Act 2004 applies.
The terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.
Meaning of optochiasmatic arachnoiditis
Death from optochiasmatic arachnoiditis
Note: terminal event is defined in the Schedule 1 – Dictionary.
On the sound medical‑scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that optochiasmatic arachnoiditis and death from optochiasmatic arachnoiditis can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the MRCA.
Note: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.
At least one of the following factors must exist before it can be said that, on the balance of probabilities, optochiasmatic arachnoiditis or death from optochiasmatic arachnoiditis is connected with the circumstances of a person's relevant service:
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
having an intrathecal myelogram or intrathecal treatment with iophendylate (Pantopaque or Myodil) before clinical onset or clinical worsening.
inability to obtain appropriate clinical management for optochiasmatic arachnoiditis before clinical worsening.
Relationship to service
The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
The clinical worsening aspect of factors set out in section 9 apply only to material contribution to, or aggravation of, optochiasmatic arachnoiditis where the person's optochiasmatic arachnoiditis was suffered or contracted before or during (but did not arise out of) the person's relevant service.
Factors referring to an injury or disease covered by another Statement of Principles
In this Statement of Principles:
then the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.
Schedule 1 - Dictionary
Note: See Section 6
1 Definitions
In this instrument:
cumulative equivalent dose means the total dose of ionising radiation received by the particular organ or tissue from external exposure, internal exposure or both, apart from normal background radiation exposure in Australia, calculated in accordance with the methodology set out in Guide to calculation of 'cumulative equivalent dose' for the purpose of applying ionising radiation factors contained in Statements of Principles determined under Part XIA of the Veterans' Entitlements Act 1986 (Cth), Australian Radiation Protection and Nuclear Safety Agency, as in force on 2 August 2017.
Note 1: Examples of circumstances that might lead to exposure to ionising radiation include being present during or subsequent to the testing or use of nuclear weapons, undergoing diagnostic or therapeutic medical procedures involving ionising radiation, and being a member of an aircrew, leading to increased levels of exposure to cosmic radiation.
Note 2: For the purpose of dose reconstruction, dose is calculated as an average over the mass of a specific tissue or organ. If a tissue is exposed to multiple sources of ionising radiation, the various dose estimates for each type of radiation must be combined.
MRCA means the Military Rehabilitation and Compensation Act 2004.
optochiasmatic arachnoiditis—see subsection 7(2).
relevant service means:
(a) eligible war service (other than operational service) under the VEA;
(b) defence service (other than hazardous service and British nuclear test defence service) under the VEA; or
(c) peacetime service under the MRCA.
Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.
terminal event means the proximate or ultimate cause of death and includes the following:
(a) pneumonia;
(b) respiratory failure;
(c) cardiac arrest;
(d) circulatory failure; or
(e) cessation of brain function.
VEA means the Veterans' Entitlements Act 1986.